Literature DB >> 3378831

Antibody to poly(ADP-ribose) as a predictor of obstetric complications in autoimmune MRL/Mp-lpr/lpr mice: basis for its application to pregnant patients with systemic lupus erythematosus.

S Isonishi1, Y Kanai.   

Abstract

In pregnant autoimmune MRL/Mp-lpr/lpr (MRL/l) mice with many fetuses the level of anti-poly(ADP-ribose) antibodies was found to be the same as that of age-matched non-pregnant female mice, whereas in mice with few fetuses the level of anti-poly(ADP-ribose) antibodies was high in the early period of pregnancy and rapidly returned to control level at puerperium. The anti-poly(ADP-ribose) antibody that increased during pregnancy seemed to be mono-specific for its antigen, whereas the antibody that increased with age was polyspecific. The isotype/subclass of the former was mainly IgG2a. The marked increase in anti-poly(ADP-ribose) antibodies in the early period of pregnancy suggests endogenous sensitization to poly(ADP-ribose), which may be synthesized abnormally or stored during pregnancy, and is a predictive sign in pregnant lupus mice of a low litter size. This finding is applicable to pregnant patients with systemic lupus erythematosus (SLE); that is, it is a predictive sign of fetal loss and/or maternal risk. This was confirmed in the human cases examined so far.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3378831     DOI: 10.1016/0165-2478(88)90071-5

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

1.  [The apoptosis marker enzyme poly-(ADP-ribose) polymerase (PARP) in systemic lupus erythematosus].

Authors:  I Böhm
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

Review 2.  Overview on poly(ADP-ribose) immuno-biomedicine and future prospects.

Authors:  Yoshiyuki Kanai
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2016       Impact factor: 3.493

3.  Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production.

Authors:  A Tominaga; S Takaki; N Koyama; S Katoh; R Matsumoto; M Migita; Y Hitoshi; Y Hosoya; S Yamauchi; Y Kanai
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.